NOR-KLEB-NET and KLEB-GAP 2024 annual meeting in Stavanger
September 18-20, 2024
The NOR-KLEB-NET and KLEB-GAP annual meeting will be held at Sola Strandhotell in September 2024.
The NOR-KLEB-NET and KLEB-GAP annual meeting was held in Lofoten in September 2022. Finally we could meet in real life for the annual meeting after three years of digital meetings. Both national and international partners and collaborators were able to travel to Ballstad in Lofoten, and we had a very successful meeting, both scientifically and social, in beautiful surroundings.
KLEB-GAP webinar, September 7-8 2021
Sept 7-8, 2021
COVID-19: NOR-KLEB-NET workshop and KLEB-GAP meeting June 2020 postponed/held virtually
FUNDING OPPORTUNITIES
June 19, 2022
We are very happy to announce that we have been granted further funding to run the NOR-KLEB-NET network for another two years by the Norwegian Research Council! We are very excited about this, especially as several of the partners of NOR-KLEB-NET met last week at Sommarøy, where we ...
Workshop August 2019
The Klebsiella pneumoniae project KLEB-GAP is lead by PI Arnfinn Sundsfjord and Co-PI Iren Høyland Löhr. KLEB-GAP is a large, new project involving several Norwegian and international institutions who aim to provide new insights into the ecology, antmicrobial resistance and pathogenicity of Klebsiella pneumoniae. Klebsiella is a key driver in the global spread of antimicrobial resistance and a target for new approaches in diagnostics, surveillance and alternative therapeutics.
ABOUT US
May 29, 2018
Funded by the Norwegian Research Council
Klebsiella pneumoniae has emerged as a high-risk human pathogen due to its virulence and increasing levels of antimicrobial resistance (AMR), and has by WHO been defined as one of the multidrug resistant (MDR) bacteria posing the greatest threat ...
The AMR group at Stavanger University Hospital and Holtlab have a new article on the convergence of virulence and MDR in a single plasmid in Klebsiella pneumoniae clone ST15. Click to read the abstract and access the full article.
Members of the AMR group at Stavanger University Hospital and Holtlab have a new article of their work on a new carbapenemase producing Klebsiella pneumoniae clone, ST307. Click to read the abstract and access the full article.